DK1799844T3 - Fremgangsmåde til påvisning af mål - Google Patents

Fremgangsmåde til påvisning af mål

Info

Publication number
DK1799844T3
DK1799844T3 DK05803987.6T DK05803987T DK1799844T3 DK 1799844 T3 DK1799844 T3 DK 1799844T3 DK 05803987 T DK05803987 T DK 05803987T DK 1799844 T3 DK1799844 T3 DK 1799844T3
Authority
DK
Denmark
Prior art keywords
lactamase
preferred embodiments
cancer
target detection
detection procedure
Prior art date
Application number
DK05803987.6T
Other languages
English (en)
Inventor
Steven W Sherwood
Original Assignee
Genencor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor Int filed Critical Genencor Int
Application granted granted Critical
Publication of DK1799844T3 publication Critical patent/DK1799844T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DK05803987.6T 2004-09-10 2005-09-09 Fremgangsmåde til påvisning af mål DK1799844T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60908204P 2004-09-10 2004-09-10
US60920504P 2004-09-10 2004-09-10
PCT/US2005/032257 WO2006031663A2 (en) 2004-09-10 2005-09-09 Methods for detecting targets

Publications (1)

Publication Number Publication Date
DK1799844T3 true DK1799844T3 (da) 2010-04-12

Family

ID=36027640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05803987.6T DK1799844T3 (da) 2004-09-10 2005-09-09 Fremgangsmåde til påvisning af mål

Country Status (11)

Country Link
US (1) US8906637B2 (da)
EP (1) EP1799844B1 (da)
AT (1) ATE452987T1 (da)
DE (1) DE602005018512D1 (da)
DK (1) DK1799844T3 (da)
ES (1) ES2337382T3 (da)
HK (1) HK1106273A1 (da)
PL (1) PL1799844T3 (da)
PT (1) PT1799844E (da)
SI (1) SI1799844T1 (da)
WO (1) WO2006031663A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019111355A1 (ja) 2017-12-06 2019-06-13 オリンパス株式会社 学習モデル作成方法、画像処理方法、学習モデル作成装置、画像処理装置、学習モデル作成プログラム、及び画像処理プログラム

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4978613A (en) 1989-01-17 1990-12-18 Abbott Laboratories Beta-lactamase assay employing chromogenic precipitating substrates
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5316906A (en) * 1991-08-23 1994-05-31 Molecular Probes, Inc. Enzymatic analysis using substrates that yield fluorescent precipitates
US5338843A (en) * 1992-01-30 1994-08-16 Becton, Dickinson And Company Fluorogenic and chromogenic β-lactamase substrates
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5677136A (en) * 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
WO2004003509A2 (en) * 2002-06-28 2004-01-08 Genepharm, Inc. A method to identify specific interaction between ligand and receptor
EP1711504A2 (en) * 2004-01-21 2006-10-18 Molecular Probes Inc. Derivatives of cephalosporin and clavulanic acid for detecting beta-lactamase in a sample

Also Published As

Publication number Publication date
US8906637B2 (en) 2014-12-09
WO2006031663A3 (en) 2006-05-11
DE602005018512D1 (de) 2010-02-04
EP1799844B1 (en) 2009-12-23
SI1799844T1 (sl) 2010-04-30
ES2337382T3 (es) 2010-04-23
PL1799844T3 (pl) 2010-05-31
EP1799844A2 (en) 2007-06-27
WO2006031663A2 (en) 2006-03-23
US20090305307A1 (en) 2009-12-10
PT1799844E (pt) 2010-03-29
HK1106273A1 (en) 2008-03-07
ATE452987T1 (de) 2010-01-15

Similar Documents

Publication Publication Date Title
WO2009067546A3 (en) Lung cancer markers and uses thereof
BRPI0906104B8 (pt) derivado de ácido peptonucleico, composição farmacêutica contendo uma quantidade terapeuticamente eficaz do derivado de ácido peptonucleico, método de utilização do derivado de ácido peptonucleico e composto
ATE556323T1 (de) Neurofibrilläre marker
DK1636586T3 (da) Enzymkatalyseret metaldeponering til foröget in situ-detektion af immunhistokemisker epitoper og nucleinsyresekvenser
BRPI0608376A8 (pt) composição de ligação, método de uso de uma composição de ligação, e, kit de detecção
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
WO2006128138A3 (en) Biodetection by nucleic acid-templated chemistry
US9631226B2 (en) Agents providing controls and standards for immunoprecipitation assays
WO2006034278A3 (en) Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
WO2001077684A3 (en) Proteomic analysis using activity-based probe libraries
DK1842226T3 (da) Homogen analytpåvisning
WO2008054600A3 (en) Compositions and methods for biodetection by nucleic acid-templated chemistry
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
WO2008048371A3 (en) Methods and compositions for highly sensitive analysis of markers and detection of molecules
WO2010006615A3 (en) Method and kit for assessing viable cells
BRPI0812488A2 (pt) Anticorpos anti-cd44 humanizados e quiméricos que mediam citotoxidade de célula de câncer, usos dos mesmos, ensaios de ligação, métodos, composições e kit de ensaio
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
Elsner et al. Burial condition is the most important factor for mtDNA PCR amplification success in Palaeolithic equid remains from the Alpine foreland
WO2006034456A3 (en) Compositions and methods for detecting and treating tumors
ATE541945T1 (de) Nachweis und quantifizierung fäkaler verunreinigungen in umweltproben
WO2007133704A3 (en) A non-nucleic acid based biobarcode assay for detection of biological materials
WO2008060483A3 (en) Protein-protein interaction biosensors and methods of use thereof
WO2004067728A3 (en) Methods and systems for the identification of rna regulatory sequences and compounds that modulate their function
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type